baber/WOPTO huggingface dataset:
Patent CA-3086257-A1 (CA)
Inventor: CHEN LIUHONG
IPC: A61P35/00
Filed: 2018-12-19
Abstract: Cette invention concerne des polypeptides qui sont liés par covalence à des échafaudages moléculaires non aromatiques de façon que deux boucles peptidiques ou plus se trouvent sous-tendues entre des points de fixation à l'échafaudage. En particulier, l'invention concerne des peptides qui sont des liants à haute affinité de la tyrosine kinase A2 du récepteur Eph (EphA2). Cette invention concerne également des conjugués médicamenteux comprenant lesdits peptides, conjugués à un ou plusieurs groupes effecteurs et/ou fonctionnels, des compositions pharmaceutiques comprenant lesdits ligands peptidiques et conjugués médicamenteux et l'utilisation desdits ligands peptidiques et conjugués médicamenteux dans la prévention, la suppression ou le traitement d'une maladie ou d'un trouble caractérisé par la surexpression de EphA2 dans des tissus malades (comme une tumeur).
Patent CA-3087302-A1 (CA)
Inventor: GUO JINGRUI
IPC: H04W72/04
Filed: 2018-12-28
Abstract: Disclosed in the present application is an uplink control information transmission method. The method may comprise: a terminal being able to determine, according to a received first DCI, whether a UCI triggered by the DCI is a highly reliable UCI, if so, design a special transmission policy for the UCI, protect the UCI, and ensure the reliability of a URLC service. In the present application, the special transmission policy may be superior to a common UCI transmission policy in at least one of: transmission resource, encoding mode, sending sequence, etc. The solution described above can provide special protection for transmission of a URLLC UCI, and ensure the high reliability of a URLC service.
Patent CA-3088350-A1 (CA)
Inventor: ALVIS SIMON
IPC: A61K47/10
Filed: 2019-01-31
Abstract: La présente invention concerne une formulation liquide appropriée pour un adénovirus du groupe B, comprenant : a) un adénovirus du groupe B, tel qu'un adénovirus du groupe B capable de se répliquer, b) de 15 à 25 % v/v de glycérol, par exemple 16, 17, 18, 19, 20, 21 % v/v de glycérol ; et c) de 0,1 à 1,5 % v/v d'éthanol, par exemple entre 0,2 et 1 %, tel que 1 % v/v d'éthanol ; et d) une solution tampon, et e) éventuellement un acide aminé, le pH de la formulation étant compris entre 8,0 et 9,6 ; l'invention concerne également l'utilisation de la formulation dans un traitement, en particulier dans le traitement du cancer.
Patent CA-3089581-A1 (CA)
Title: Use of pyridoxal acetal salts as water-triggered pro-fragrances
Inventor: BOYCE GREGORY R
IPC: C07D221/04
Filed: 2019-01-24
Abstract: A pro-fragrance delivery system based on a vitamin scaffold and a fragrant alcohol. The vitamin scaffold may be a vitamer of vitamin B6 or derivatives thereof. The pro-fragrance releases the fragrant alcohol by action of water at neutral pH.
Patent CA-3090049-A1 (CA)
Title: Multilayer lens for eyeglasses
Inventor: DEGLI ANTONINI GIORGIO
IPC: G02B1/115
Filed: 2019-02-13
Abstract: A multilayer lens for eyeglasses, which comprises a substrate (2), and at least one layer (5) of precious metal; the layer (5) of precious metal is arranged on the concave side of the substrate (2) adapted to be directed toward the eye of the wearer of the lens.
Patent CA-3090811-A1 (CA)
Inventor: MACGREGOR IAN
IPC: B65B5/04
Filed: 2019-03-12
Abstract: L'invention concerne des procédés pour un instrument comprenant une source de lumière. Un procédé pour un instrument comprenant une source de lumière consiste à fournir de la lumière de la source de lumière à un emplacement cible dans une chambre de traitement. Le procédé comprend la réception de la lumière au niveau d'un capteur. Le procédé consiste à déterminer, à l'aide de données provenant du capteur, une première position de la lumière à l'emplacement cible. De plus, le procédé consiste à déterminer s'il faut ajuster la lumière à une seconde position au niveau de l'emplacement cible. L'invention concerne également des instruments associés.
Patent CA-3091136-A1 (CA)
Inventor: HOTTA AKITSU
IPC: C12N5/10
Filed: 2019-02-15
Abstract: La présente invention concerne un procédé de production, à partir d'une cellule donneuse, d'une cellule faiblement antigène pour laquelle une réaction de rejet dans le cas d'une allogreffe à un destinataire est réduite. Le procédé comprend : la détermination de la cellule donneuse et d'un allèle d'antigène leucocytaire humain (HLA) du destinataire ; la spécification d'un allèle HLA qui n'est pas présent chez le destinataire mais présent dans la cellule donneuse ; et la destruction ou la modification de l'allèle HLA spécifié, et l'obtention d'une population de cellules contenant des cellules qui n'expriment pas une protéine HLA spécifique de la cellule donneuse, la cellule qui n'exprime pas une protéine HLA spécifique de la cellule donneuse étant la cellule faiblement antigène.
Patent CA-3092136-A1 (CA)
Title: Procede de reduction des dommages causes aux cultures
Inventor: BICKERS UDO
IPC: A01P13/00
Filed: 2019-02-26
Abstract: La présente invention concerne un procédé de réduction des dommages causés aux cultures, par un traitement de la semence des cultures avec le phytoprotecteur avant le semis. Ceci peut être réalisé en plus de l'utilisation de combinaisons/compositions de protection des cultures, en particulier des combinaisons herbicide/phytoprotecteur et des compositions les comprenant, qui sont hautement appropriées pour la protection des cultures contre des dommages causés par des herbicides dans des traitements avant la levée et après la levée.
Patent CA-3093167-A1 (CA)
Inventor: ANGMAN PER G
IPC: F16K31/12
Filed: 2019-03-05
Abstract: A thermal expansion system for actuating a remote operated sleeve assembly to open and close ports in a housing for fluidly communicating between a bore of a tubular string in a wellbore to the formation utilizes actuation of a propellant charge to create expanding gas and heat in a combustion chamber to directly act on one side of a piston connected to an axially moveable sleeve supported in the housing to shift the sleeve in one direction. Ignition of another propellant charge in a combustion chamber on an opposing side of the piston is used to directly shift the sleeve in an opposing direction.
Patent CA-3095323-A1 (CA)
Title: Systemes et procedes d'affichage et d'interaction a ecrans multiples
Inventor: UTUKURI AVANINDRA
IPC: G09G5/12
Filed: 2019-03-26
Abstract: La présente invention concerne divers systèmes et procédés d'interaction à écrans multiples. Le contenu et les objets d'un premier dispositif d'affichage sur un premier écran peuvent être transférés vers d'autres dispositifs d'affichage sur d'autres écrans à l'aide de divers gestes. Dans certains modes de réalisation, des régions actives sur le premier dispositif d'affichage correspondent à divers autres dispositifs d'affichage, et des gestes correspondant aux régions actives permettent le transfert de contenu ou d'objets sur le premier dispositif d'affichage vers les autres dispositifs d'affichage. Dans certains modes de réalisation, le contenu peut comprendre un contenu audio, qui peut être reproduit au niveau de divers dispositifs de sortie audio sélectionnés à partir du premier dispositif d'affichage.
Patent CA-3095599-A1 (CA)
Title: Method of synthesizing a radiopharmaceutical
Inventor: JACKSON ALEXANDER
IPC: G16C20/10
Filed: 2019-03-29
Abstract: The present invention relates a method of monitoring an automated radiosynthesizer during a run and the radiosynthesizer having a number of individual activity detectors operably associated therewith. The method comprises the steps of recording S10 activity data from each activity detector; accessing S20 historic data from a data storage; detecting S30 precursor of yield drop in the recorded activity data based on the historic data; predicting (S40 yield when synthesizing a tracer with the radiosynthesizer based on the detected precursor of yield drop; and initiating S50 actions related to a level of predicted yield.
Patent CA-3095921-A1 (CA)
Inventor: PIENADO RENE E
IPC: B28C9/04
Filed: 2019-04-04
Abstract: Un procédé représentatif pour la séquestration de CO2 peut comprendre l'étape consistant à séquestrer au moins une partie d'un gaz CO2 émis pendant le fonctionnement du système de production de béton prêt à l'emploi dans (i), un béton prêt à l'emploi produit par le système de production de béton prêt à l'emploi, et/ou (ii) du carbonate de calcium formé par traitement de l'eau utilisée pendant le fonctionnement du système de production et de distribution de béton prêt à l'emploi.
Patent CA-3098429-A1 (CA)
Title: Self-healing durable cement
Inventor: AL-YAMI ABDULLAH
IPC: C04B18/22
Filed: 2018-06-28
Abstract: According to at least one embodiment of the present description, a cement slurry includes 1% to 90% BWOC of a cement precursor material based on the total weight of the cement slurry; and from 1% to 40% BWOC of a swelling additive based on the total weight of the cement slurry. The swelling additive comprises at least one micronized rubber, at least one distillate, and at least one solvent-refined heavy paraffinic.
Patent CA-3103773-A1 (CA)
Title: Dehydrogenation catalyst
Inventor: MAEDA SHUN
IPC: C07C11/04
Filed: 2019-12-03
Abstract: Provided is a dehydrogenation catalyst with which it is possible to suppress caulking and increase the yield of an olefin in a thermal decomposition reaction of a hydrocarbon raw material. This dehydrogenation catalyst (4A) used in the manufacture of an olefin contains at least one element of La and Ce as a catalyst component. The dehydrogenation catalyst (4A) contains at least one element selected from the group consisting of Ba, Fe, and Mn when the dehydrogenation catalyst (4A) does not contain Ce. The dehydrogenation catalyst (4A) contains at least one element of Fe and Mn when the dehydrogenation catalyst (4A) contains Ce.
Patent CA-3107461-A1 (CA)
Title: Methods of treating overactive bladder using trospium
Inventor: GIESING DENNIS
IPC: A61P13/06
Filed: 2019-07-31
Abstract: The present application provides methods of treating overactive bladder and methods of training or retraining bladder, prolonging symptom relief, improving the quality of life and/or neuronal remodeling in an individual having overactive bladder, by administering an effective amount of trospium locally to the bladder of the individual for at least about 24 hours.
Patent CA-3108184-A1 (CA)
Inventor: BLANCHETTE GUILLAUME
IPC: H04B1/40
Filed: 2021-02-05
Abstract: There are described methods and devices for intra-spacecraft communication in space, the electro-optical device having at least one of transmitting capabilities for converting a first electrical signal into a first optical signal and outputting the first optical signal within a spacecraft, and receiving capabilities for receiving a second optical signal within the spacecraft and converting the second optical signal into a second electrical signal, the electro-optical device having at least one integrated circuit dedicated to at least one of the transmitting capabilities and the receiving capabilities, the at least one integrated circuit configured for operating in an analog mode where configuration voltages for the integrated circuit are provided by analog voltage settings unaffected by radiation.
Patent CA-3108227-A1 (CA)
Inventor: GIASOLLI ROBERT
IPC: A61B17/064
Filed: 2011-07-08
Abstract: ABSTRACT A system for delivering a vascular prosthesis includes an elongate body including a distal end, a proximal end, and a plunger disposed adjacent the distal end. The system includes an elongate packet having a plurality of intravascular tacks coupled therewith and disposed along the length of the elongate packet. The system includes a sheath having a proximal end and a distal end, the sheath being moveable relative to the elongate body from a first position in which the sheath distal end is disposed distally of at least a portion of the elongate packet to a second position in which the sheath distal end is disposed proximally of the elongate packet. The elongate packet is configured to maintain a minimum spacing between adjacent tacks during deployment and to permit expansion and separation from the elongate body, and to release the tacks to expand toward a vessel wall after deployment. Date Recue/Date Received 2021-02-05
Patent CA-3111541-A1 (CA)
Title: Luminaire structure
Inventor: PORTER THEODORE
IPC: F21V15/01
Filed: 2021-03-09
Abstract: Disclosed is a luminaire structure including a housing structure defming at least one light output region that may be at least partially enclosed and/or recessed, and bordered by at least two opposed housing boundary regions. The housing boundary regions define at least one light delivery zone spaced from the light output region, to deliver light to at least one adjacent interior space. At least one first sensor is configured to sense at least one parameter within a sensing field adjacent the at least one first sensor, while a positioning structure is configured to position the at least one first sensor at an operative sensor location at least partially enclosed or recessed, and adjacent the light delivery zone. The operative sensor location and the at least two opposed boundary regions may be configured to present the sensing field to the adjacent interior space without operative obstruction by the at least two opposed boundary regions.
Patent CA-3114257-A1 (CA)
Title: Unsintered expanded polytetrafluoroethylene composite membranes having dimensional stability
Inventor: EBATA YURI
IPC: B01D71/36
Filed: 2018-10-04
Abstract: A method of forming an unsintered biaxially expanded PTFE/thermoplastic polymer composite membrane is provided. The method includes blending fibrillatable polytetrafluoroethylene (PTFE) particles and thermoplastic polymer particles where the melting point of the thermoplastic polymer particles is less than the melting point of the fibrillatable PTFE particles. The method further includes forming the blend into a tape and expanding and heating the tape in a first direction at a first temperature. The expanded tape is then expanded, either concurrently or sequentially in a second direction to form an ePTFE composite membrane. The method does not include a sintering temperature. The ePTFE particles and thermoplastic polymer particles have an average particle size of less than 1 µm. In addition, the ePTFE composite membrane has a geometric mean matrix modulus to geometric mean matrix tensile strength ratio of at least about 6 and an absolute dimensional change percentage of less than about 1.5%.
Patent CA-3114352-A1 (CA)
Inventor: PANOSIAN MICHAEL H
IPC: B25H3/00
Filed: 2021-04-08
Abstract: A spill-resistant pouch is attachable to a belt and has a pocket having spaced proximal and distal walls when worn on the belt of a user. The pocket has an upper opening for receiving objects within the pouch. The upper opening, when not subjected to loading stresses, nounally defines a predeteunined dimension extending between the proximal and distal walls, the pocket normally being deformable along the predetermined direction in response to forces applied by objects within the pocket on the distal wall. A rigidifying structure is provided within the pocket for substantially maintaining the predetermined dimension of the upper opening by preventing relative movements between the proximal and distal walls, whereby objects within the pocket are prevented from falling out through the upper opening due to excessive defounation of the distal wall relative to the proximal wall while providing unhindered access to items within the pouch.
Patent CA-3121587-A1 (CA)
Title: Carrying arrangement for accommodating a baby or infant
Inventor: SCHACHTNER PETRA
IPC: A47D13/02
Filed: 2019-10-23
Abstract: The invention relates to a carrying arrangement (1) having an accommodating structure (10) for accommodating a baby or infant (B), wherein the accommodating structure (10) has an inner side (S1) and an outer side (S2) and is designed such that at least one region of the rear side (B1) of a baby or infant (B) can be accommodated and/or supported in the accommodating structure (10), and having a harness system (40) for fastening the accommodating structure (10) on a person (P). The accommodating structure (10) has a central part (11) comprising an upper end (12), a lower end (13), a left-hand side edge (14) and a right-hand side edge (15) and also has a left-hand length of cloth (31) and a right-hand length of cloth (32), wherein, in the region of the upper end (12), the central part (11) has a left-hand pull-through tunnel (16), through which the left-hand length of cloth (31) is guided, and a right-hand pull-through tunnel (17), through which the right-hand length of cloth (32) is guided. The region of the upper end (12) of the central part (11) is mounted such that it can be displaced, by way of the left-hand and right-hand pull-through tunnels (16, 17), along the left-hand and right-hand lengths of cloth (31, 32).
Patent CA-3124277-A1 (CA)
Inventor: ANDREY NICOLAS
IPC: B65D5/74
Filed: 2019-12-20
Abstract: A package closure system may include a package outlet including a first connection element and a cap configured to removably connect to the package outlet using the first connection element and comprising a second connection element. An overcap can be configured to removably connect to the cap using the second connection element. A method for providing a nutritional composition from a container to an enteral line may include: removing an overcap from a cap, the cap is configured to direct a nutritional composition through a channel within the cap, the cap removably connected to the container; connecting the cap sealingly to the enteral line; and applying a pressure to the container to direct the nutritional composition from the container through the channel and into the enteral line.
Patent CA-3125150-A1 (CA)
Inventor: ANAND PJ
IPC: A61M37/00
Filed: 2012-08-01
Abstract: The methods, systems, and devices disclosed herein generally involve convection-enhanced delivery of drugs to a target region within a'patient. Microfluidic catheter devices are disclosed that are particularly suitable for targeted delivery of drugs via convection, including devices capable of multi-directional drug delivery, devices that control fluid pressure and velocity using the venturi effect, and devices that include conformable balloons. Methods of treating various diseases using such devices are also disclosed, inchiding methods of treating cerebral and spinal cavernous malformations, cavernomas, and hemangiomas, methods of treating neurological diseases, methods of treatment using multiple microfluidic delivery devices, methods of treating hearing disorders, methods of spinal drug delivery using microfluidic devices, and methods of delivering stem cells and therapeutics during fetal surgery. Methods of manufacturing such devices are also disclosed.
Patent CA-3125344-A1 (CA)
Title: Methods and associated systems for determining compliance of a part having an uneven profile with a reference drawing
Inventor: BEAUCHEMIN PATRICK
IPC: G06T3/20
Filed: 2020-11-13
Abstract: There are provided a method and associated system for determining compliance of a part having teeth, crests or roots with a reference drawing. The method includes providing an image of the part; overlaying and aligning the reference drawing with the image of the part; analyzing the image of the part with the aligned overlay to extract a plurality of measurement points on the image of the part, each being associated with a corresponding crest or root of the teeth; and comparing the image of the part to the reference drawing in the crest or root regions to determine if the part is within a predetermined tolerance at each measurement point. The method is particularly suited for the inspection of parts having an uneven profile.
Patent CA-3128611-A1 (CA)
Title: Packaging material comprising indicator responding to an external stimulus
Inventor: ZERFAS PAUL ANTHONY
IPC: G01D5/00
Filed: 2018-08-13
Abstract: PACKAGING MATERIAL COMPRISING INDICATOR RESPONDING TO AN  EXTERNAL STIMULUS ABSTRACT A packaging material for use in a package having contents including a food item, the packaging material includes a layer including an additive transformable frorn a first state to a second state in response to an external stimulus and a barrier layer positionable between said layer and the contents of the package. The barrier layer restricts diffusion of said additive to the contents. #47110430 Date Recue/Date Received 2021-08-17
Patent CA-3129106-A1 (CA)
Inventor: ALLARD AURORE
IPC: A61K47/68
Filed: 2020-02-06
Abstract: La présente invention concerne des méthodes de traitement de cancers exprimant une concentration élevée de CEACAM5, notamment des cancers du poumon de type NSCLC NSQ, à l'aide d'immunoconjugués comprenant un anticorps qui se lie spécifiquement à la CEACAM5 humaine.
Patent CA-3129898-A1 (CA)
Inventor: CHRETIEN LUDOVIC ANDRE
IPC: F04D27/00
Filed: 2020-02-10
Abstract: La présente invention concerne un système CVCA comprenant un compresseur à capacité multiple, et un système de commande du compresseur à capacité multiple. Le système de commande comprend une source de tension alternative du secteur, un variateur de fréquence et de tension, et un processeur. La source de tension alternative du secteur est conçue pour faire fonctionner le compresseur à capacité multiple. Le variateur de fréquence et de tension est couplé à la source de tension alternative du secteur et est conçu pour faire fonctionner le compresseur à capacité multiple à une vitesse variable. Le processeur est couplé à la source de tension alternative du secteur et au variateur de fréquence et de tension, et est conçu pour coupler sélectivement la source de tension alternative du secteur et le variateur de fréquence et de tension au compresseur à capacité multiple pour faire fonctionner le compresseur à capacité multiple. Le processeur est en outre configuré pour transmettre un signal de commande de capacité au compresseur à capacité multiple. Le signal de commande de capacité reçoit des instructions pour mettre en uvre le compresseur à capacité multiple selon un réglage d'une pluralité de réglages de capacité.
Patent CA-3129901-A1 (CA)
Title: Therapeutic antibody formulation
Inventor: CORVARI VINCENT JOHN
IPC: A61K9/08
Filed: 2020-02-11
Abstract: Stable aqueous pharmaceutical formulations for therapeutic antibodies and methods of using such stable aqueous pharmaceutical formulations.
Patent CA-3132213-A1 (CA)
Title: Compositions de catalyseur a promoteur de ruthenium
Inventor: GIDDEY SARBJIT SINGH
IPC: B01J29/03
Filed: 2020-03-05
Abstract: La présente invention concerne des compositions de catalyseur à promoteur de ruthénium. Les compositions de catalyseur à promoteur de ruthénium comprennent une espèce métallique de ruthénium, un matériau support d'oxyde et une espèce de promoteur choisie indépendamment dans le groupe constitué par La, Rb, Y, Yb, K, Cs et Ba, ou les hydroxydes, nitrates ou oxydes de ceux-ci. La présente invention concerne également divers procédés, processus, systèmes, membranes et/ou réacteurs qui peuvent utiliser ces compositions de catalyseur à promoteur de ruthénium, par exemple dans la synthèse d'ammoniac.
Patent CA-3133185-A1 (CA)
Inventor: ROSCH JASON W
IPC: A61K39/09
Filed: 2020-03-12
Abstract: Compositions and methods are provided for reducing the mammalian transmission of Streptococcus pneumoniae (S. pneumoniae) through the administration to mammalian subjects of vaccine compositions comprising at least one immunogenic polypeptide comprising a S. pneumoniae protein or a fragment or variant thereof that is required for or involved in transmission of the bacteria between mammalian hosts. These vaccine compositions also serve to reduce the incidence rate of at least one invasive disease caused by S. pneumoniae. Methods are also provided for identifying additional genetic factors involved in mammalian transmission of S. pneumoniae.